NIFTY
15.40  0.15%
 10342.30
S&P BSE SENSEX
83.20  0.25%
 33561.55
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 22-Nov-2017
NSE
-10.5    -1.48%
Rs. 698.35
 
Days Low
Rs. 695.5
Days High
Rs. 711.5

Open Rs. 711
 
52 week Low
Rs. 504
52 week High
Rs.808.95
 
 
Bid :                 0.00 (0)
Offer :        698.80 (124)
BSE
Rs.698.80
-10.6    -1.49%
on 22-Nov-2017
BSE
-10.6    -1.49%
Rs. 698.80
 
Days Low
Rs. 694
Days High
Rs. 712

Open Rs. 710
 
52 week Low
Rs. 503.05
52 week High
Rs.809.45
 
 
Bid :                 0.00 (0)
Offer :        698.80 (124)
NSE
Rs.698.35
-10.5    -1.48%
 
 
Last Price (Rs.)  698.80 Value  81305692.00
Net Change (Rs.)  -10.60 Best Buy  0.00
Volume  115873 Best Sell  698.80
Prev.Close (Rs.)  709.40 Best Quantity  0
Open (Rs.)  711.00 Sell Quantity  124
High (Rs.)  711.50 52-Week High (Rs.)  808.95
Low (Rs.)  695.50 52-Week Low (Rs.)  504.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  409414.63
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Currents Investments0.20 0.20 196.40 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 535.20 1284110 81.15 0.00 0.65
Cipla 618.85 498064 167.17 51.07 0.32
Cadila Healthcare 442.70 453211 70.16 68.49 0.72
Piramal Enterprises 2601.40 448906 807.03 57.79 0.81
Dr. Reddys Lab 2361.35 391718 682.01 28.29 0.85
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Sep 2017Jun 2017Mar 2017
Net Sales30738.6021882.9024200.90
Operating Profit10680.705002.606312.10
PBDT10560.504900.106221.50
Net Profit7528.303073.304554.60
More> 
 
Company News
11/22/2017 12:00:00 AM
Aurobindo Pharma informs about schedule of analyst call
11/20/2017 12:00:00 AM
Updates
11/18/2017 12:00:00 AM
Aurobindo Pharma informs about company updates
More>
 
Ratios
   Earnings Per Share (Rs)29.13 
   Book NAV/Share(Rs)143.99 
   PAT Margin (%)17.45 
   Asset Turnover(x)0.76 
   PER(x)23.18 
   Yield(%)0.37 
   EV/Core EBITDA(x)16.96 
   M Cap / Sales4.12 
   Net Sales Growth(%)4.81 
   PAT Growth(%)4.92 
   Total Debt/Equity(x)0.36 
   Current Ratio(x)1.55 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>